Quick Answer
NextCure, Inc. reported Stockholders Equity of $34.94 million for fiscal year 2025.
NextCure, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $34.94M | -46.6% |
| 2024 | $65.47M | -42.8% |
| 2023 | $114.42M | -31.7% |
| 2022 | $167.53M | -28.2% |
| 2021 | $233.39M | -20.5% |
| 2020 | $293.72M | -8.6% |
| 2019 | $321.48M | +784.8% |
| 2018 | -$46.94M | -92.3% |
| 2017 | -$24.41M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $23.65M | -68.7% | -20.2% |
| June 30, 2025 | $29.65M | -65.3% | -46.9% |
| March 31, 2025 | $55.85M | -43.6% | -14.7% |
| December 31, 2024 | $65.47M | -42.8% | -13.4% |
| September 30, 2024 | $75.59M | -40.2% | -11.5% |
| June 30, 2024 | $85.44M | -38.3% | -13.7% |
| March 31, 2024 | $99.05M | -35.8% | -13.4% |
| December 31, 2023 | $114.42M | -31.7% | -9.5% |
- NextCure, Inc. showed a decrease of -46.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2017–2025 period, NextCure, Inc.’s stockholders equity has grown by 243.1% (from -$24.41 million to $34.94 million).
- The most recent figure is from NextCure, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: